Sensorineural deafness following routine transurethral resection of the prostate. | Canada Hyperbarics Skip to main content
Clinical Study BMJ case reports 2015

Sensorineural deafness following routine transurethral resection of the prostate.

Bowsher B — BMJ case reports, 2015

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported a case of a man who developed complete unilateral hearing loss after transurethral resection of the prostate.

What They Found

A man in his 50s developed total sensorineural deafness by day three post-surgery, progressing from muffled hearing and tinnitus. He had received 240 mg of intravenous gentamicin intraoperatively, leading to a working diagnosis of gentamicin-induced ototoxicity.

What This Means for Canadian Patients

Canadian patients undergoing surgery, particularly those receiving gentamicin, should be aware of the rare but severe risk of ototoxicity. Early recognition of symptoms like muffled hearing or tinnitus post-surgery is crucial, though intervention may not always be successful.

Canadian Relevance

This case report has no direct Canadian connection, but the findings are relevant to surgical practices and patient care globally.

Study Limitations

As a single case report, the findings are not generalizable to the broader patient population.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Neurological
Source Pubmed
PubMed ID 26564118
Year Published 2015
Journal BMJ case reports
MeSH Terms Adrenal Cortex Hormones; Anti-Bacterial Agents; Australia; Dexamethasone; Disability Evaluation; Gentamicins; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Prostatic Neoplasms; Transurethral Resection of Prostate; Treatment Failure

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.